Company Filing History:
1 out of 1,382 
1 out of 818 
Years Active: 2017
Title: Scott Lucia - Innovator in Cancer Treatment
Introduction
Scott Lucia is a notable inventor based in Aurora, Colorado, recognized for his significant contributions to cancer treatment. His innovative approach focuses on a targeted method for treating triple-negative breast cancer, a particularly aggressive form of the disease.
Latest Patents
Scott Lucia holds a patent for a method of treating triple-negative breast cancer using AMPI-109. This compound exhibits remarkable cancer-specific characteristics, demonstrating a targeted capability to inhibit the proliferation of TN breast cancer cells and induce apoptosis in these cells. Notably, the growth inhibitory effect of AMPI-109 operates independently of VDR. Furthermore, AMPI-109 can be combined with other oncolytic agents to enhance treatment efficacy for patients suffering from TN breast cancer.
Career Highlights
Throughout his career, Scott has worked with prestigious institutions such as the University of Colorado and Boston University. His work in these environments has allowed him to develop and refine his innovative approaches to cancer treatment.
Collaborations
Scott has collaborated with notable colleagues, including Hamid Gari and Jim Lambert, contributing to advancements in cancer research and treatment methodologies.
Conclusion
Scott Lucia's work in developing AMPI-109 represents a significant advancement in the fight against triple-negative breast cancer. His innovative methods and collaborations highlight the importance of targeted therapies in modern medicine.